Literature DB >> 18449910

Genome-wide scan in 124 Indonesian sib-pair families with schizophrenia reveals genome-wide significant linkage to a locus on chromosome 3p26-21.

S G Schwab, H Y Handoko, A Kusumawardhani, I Widyawati, N Amir, M W S Nasrun, P Holmans, M Knapp, D B Wildenauer.   

Abstract

Variation in incidence of schizophrenia between populations with different ethnical background may reflect population specific differences in nature and composition of genetic and environmental factors. In order to investigate whether there are population specific susceptibility genes for schizophrenia, we collected in Indonesia families with two or more affected siblings and, as far as available, parents and unaffected siblings, suitable for genetic linkage- and association studies. After checking extensively for incompatibilities with Mendelian inheritance as well as for errors in sampling, we used 124 families from the sample of 152 originally ascertained families for linkage analysis. Genotyping was performed at the NHLBI Mammalian Genotyping Service at Marshfield Research Organisation using the Screening Set 16, which comprises 402 Short Tandem Repeat Polymorphisms (STRPs). The genotypes of 540 individuals including 267 affected with schizophrenia were used for analysis. Multipoint sib-pair linkage analysis was carried out by estimation of--allele sharing derived--maximum likelihood LOD scores (MLS) in 154 sib-pair combinations. We obtained a genome-wide significant MLS of 3.76 on chromosome 3p26.2-25.3. Genome-wide significance was estimated by performing 10,000 simulated genomescans. Additional loci were detected on 1p12, which produced suggestive evidence for linkage (MLS = 2.35), as well as on 5q14.1 (MLS = 1.56), 5q33.3 (MLS = 1.11), and 10q (MLS = 1.17), where linkage had been reported previously. In conclusion, our study detected a region with genome-wide significant linkage, which will serve as starting point for identification of schizophrenia susceptibility genes in the Indonesian population.

Entities:  

Mesh:

Year:  2008        PMID: 18449910     DOI: 10.1002/ajmg.b.30763

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  8 in total

Review 1.  Family-based designs for genome-wide association studies.

Authors:  Jurg Ott; Yoichiro Kamatani; Mark Lathrop
Journal:  Nat Rev Genet       Date:  2011-06-01       Impact factor: 53.242

2.  GRM7 polymorphisms and risk of schizophrenia in Iranian population.

Authors:  Iman Azari; Reza Hosseinpour Moghadam; Hamid Fallah; Rezvan Noroozi; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2019-01-04       Impact factor: 3.584

3.  Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients.

Authors:  Yang Wang; Lei Wang; Xingwang Li; Baocheng Liu; Qingzhu Zhao; Peng Chen; Ti Wang; Tao Li; Jue Ji; Fengping Yang; Quan Wang; Jinfen Wang; Yanzeng Xiao; Yifeng Xu; Guoyin Feng; Zhihai Peng; Lin He; Guang He
Journal:  BMC Cancer       Date:  2010-10-04       Impact factor: 4.430

4.  Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.

Authors:  Anna Alkelai; Lior Greenbaum; Sara Lupoli; Yoav Kohn; Kyra Sarner-Kanyas; Edna Ben-Asher; Doron Lancet; Fabio Macciardi; Bernard Lerer
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

5.  Using multivariate machine learning methods and structural MRI to classify childhood onset schizophrenia and healthy controls.

Authors:  Deanna Greenstein; James D Malley; Brian Weisinger; Liv Clasen; Nitin Gogtay
Journal:  Front Psychiatry       Date:  2012-06-01       Impact factor: 4.157

6.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Authors:  M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis
Journal:  Mol Psychiatry       Date:  2008-12-30       Impact factor: 15.992

7.  A Novel Microduplication in the Neurodevelopmental Gene SRGAP3 That Segregates with Psychotic Illness in the Family of a COS Proband.

Authors:  Nicole K A Wilson; Yohan Lee; Robert Long; Karen Hermetz; M Katharine Rudd; Rachel Miller; Judith L Rapoport; Anjené M Addington
Journal:  Case Rep Genet       Date:  2011-09-12

Review 8.  Genome-wide association studies in ADHD.

Authors:  Barbara Franke; Benjamin M Neale; Stephen V Faraone
Journal:  Hum Genet       Date:  2009-04-22       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.